Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasoconstriction Trial of LEO 90100 Foam
NCT02973776Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV) (6 arms), sponsored by LEO Pharma. Primary endpoint: Visual Skin Blanching Score. Started Dec 2016; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02973776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02973776.